Clinical Trials Directory

Trials / Completed

CompletedNCT06442891

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

A Pilot Study of Self-Administered Acupressure for Fatigue Among Adolescent and Young Adult (AYA) Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University of Michigan Rogel Cancer Center · Academic / Other
Sex
All
Age
15 Years – 39 Years
Healthy volunteers
Not accepted

Summary

This clinical trial tests the feasibility of self-administered relaxing acupressure on fatigue in adolescent and young adult (AYA) cancer survivors. Acupressure, a type of complementary or alternative medicine, is the application of pressure or localized massage to specific sites on the body to control symptoms. Relaxing acupressure has been shown to improve cancer-related fatigue (CRF) in adults, however, less is known about the impact of relaxing acupressure on CRF in AYA cancer survivors."

Detailed description

PRIMARY OBJECTIVE: I. Determine the feasibility of implementing a randomized controlled trial of a six-week, self-administered relaxing acupressure intervention in AYA cancer survivors with clinically relevant CRF. SECONDARY OBJECTIVE: I. Explore participants' perspectives of acceptability and satisfaction with the six-week acupressure interventions using semi-structured interviews. EXPLORATORY OBJECTIVE: I. Determine the preliminary efficacy of a six-week, virtual, self-administered relaxing acupressure intervention on clinically significant changes in CRF in post-treatment AYA cancer survivors. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive access to an acupressure mobile application and an AcuWand on study and self-administer relaxing acupressure to 9 acupoints over 27 minutes once daily (QD) for 6 weeks. ARM II: Patients receive access to an acupressure mobile application and an AcuWand and self-administer sham acupressure to non-acupressure point locations over 27 minutes QD for 6 weeks. Enrollment was increased to 45.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcupressure TherapySelf-administer relaxing acupressure
PROCEDUREAcupressure TherapySelf-administer sham acupressure
OTHERInternet-Based InterventionReceive access to acupressure mobile app
OTHERInterviewAncillary studies
OTHERMedical Device Usage and EvaluationReceive an AcuWand
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2024-10-01
Primary completion
2025-12-22
Completion
2025-12-22
First posted
2024-06-04
Last updated
2026-01-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06442891. Inclusion in this directory is not an endorsement.